Buformin
| Clinical data | |
|---|---|
| Routes of administration  | Oral | 
| ATC code | |
| Pharmacokinetic data | |
| Excretion | Renal | 
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| PDB ligand | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.662 | 
| Chemical and physical data | |
| Formula | C6H15N5 | 
| Molar mass | 157.221 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
| (what is this?) (verify) | |
Buformin (1-butylbiguanide) is an oral antidiabetic drug of the biguanide class, chemically related to metformin and phenformin. Buformin was marketed by German pharmaceutical company Grünenthal as Silubin.